Skin-to-skin contact is key for preterm infants. Research shows that quality improvement initiatives can increase this vital bonding time, but challenges persist for intubated or medically complex babies.
SkinCareRadar tracks newly published skincare and dermatology research, then explains what the findings mean in plain language — with evidence labels, source links, and no hype.
Skin-to-skin contact is key for preterm infants. Research shows that quality improvement initiatives can increase this vital bonding time, but challenges persist for intubated or medically complex babies.
Small Human StudySmall or uncontrolled human study. Results are preliminary.Published: March 25, 2026
Vasculopathic skin lesions may be a sign of rare autoimmune disease
Researchers studied a rare autoimmune disease called anti-MDA5 dermatomyositis, which can cause skin lesions and muscle weakness. They found that some patients may have skin lesions that are a sign of the disease, but are often overlooked. This disease can be difficult to diagnose and may lead to serious health problems if not treated early.
Why it matters: Understanding this disease may help doctors diagnose and treat it more effectively, which could improve patient outcomes.
This study is based on a single case, and more research is needed to confirm these findings.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.TretinoinAcnePublished: March 25, 2026
L-Carnitine May Help with Skin Issues and Acne
Researchers studied L-Carnitine, an amino acid, for its potential benefits in dermatology. They found it may help reduce acne, sebum production, and post-inflammatory hyperpigmentation when applied topically. Systemic L-Carnitine may also help with inflammation, skin elasticity, and wound healing in certain conditions.
Why it matters: This research may lead to new treatments for various skin disorders and improve our understanding of skin health.
The review included 59 studies, but most were small or focused on specific conditions. Further dermatology-specific trials are needed to optimize dosing, formulations, and long-term safety.
In VitroCell or tissue culture experiments. No human or animal data.Published: March 24, 2026
Spirohydantoin Derivatives May Help Fight Aggressive Brain Tumors
Researchers studied spirohydantoin derivatives, a type of compound, to see if they could help fight glioblastoma, an aggressive brain tumor. They found that some of these compounds were more effective at killing cancer cells than a commonly used chemotherapy drug. However, more research is needed to understand how these compounds work and their potential benefits.
Why it matters: This study may help us better understand how certain compounds interact with cancer cells, which could potentially lead to new treatments for skin conditions or other diseases.
This study was conducted in a lab using human brain tumor cells and does not involve human subjects. The results may not translate to other types of cancer or skin conditions.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Published: March 24, 2026
Hyperparathyroidism's Impact on Bone Metabolism and Treatment
Researchers looked back at the history of hyperparathyroidism, a condition affecting bone metabolism, and found that surgical treatment has evolved over time. Initially, a more invasive approach was used, but now a less invasive technique is preferred. This shift may help improve patient outcomes.
Why it matters: Understanding the treatment of hyperparathyroidism may have implications for the management of related skin conditions, such as those caused by calcium imbalances.
This study is a historical review and does not present new evidence. It is based on existing research and clinical practices.
Niacinamide skin permeation may be influenced by pH levels
Researchers studied how different pH levels affect the way niacinamide, a common skincare ingredient, passes through the skin. They found that a neutral pH may increase niacinamide's permeation, but more research is needed to understand this effect. The study also looked at how pH changes the skin's electrical properties and how it affects the conversion of niacinamide into another compound.
Why it matters: Understanding how pH affects niacinamide's skin permeation may help skincare product developers create more effective products.
This study used full-thickness human skin and 3D reconstructed epidermal tissue models in lab experiments, and its findings may not directly apply to real-world skincare products or individual skin types.
In VitroCell or tissue culture experiments. No human or animal data.Skin Barrier DamagePublished: March 24, 2026
New Lab Method May Help Study Skin Barrier Integrity
Researchers developed a new method to study the skin's barrier function in lab-grown human skin cells. This method can help assess how well the skin's barrier works and how certain proteins affect it. The method involves measuring the skin's electrical resistance and using special dyes to see how well the skin's barrier holds up. It also helps researchers understand how certain proteins, like claudins, are expressed in the skin.
Why it matters: Understanding the skin's barrier function may help researchers develop new treatments for skin conditions and improve our understanding of how the skin works.
This study was conducted in lab-grown human skin cells and has not been tested in humans. The results may not directly apply to people with skin conditions or in real-world situations.
SkinCareRadar is a public research monitor focused on skincare ingredients, routines, devices, and skin conditions and concerns. It translates dermatology and cosmetic science research into plain language for the general public.
Every finding is linked to its original source. Evidence stages are labeled clearly. We do not diagnose, recommend treatment, or give medical advice. We distinguish cosmetic improvement from medically significant outcomes.